1. Reactive arthritis following Bacillus Calmette-Guérin immunotherapy
- Author
-
Carolina Muñoz-Grajales, Javier Darío Márquez Hernández, Cristian García, José Jaime Correa, Carlos Jaime Velásquez Franco, Sergio Cardozo, and Luis Fernando Pinto Peñaranda
- Subjects
Bacillus (shape) ,Mycobacterium bovis ,biology ,business.industry ,medicine.medical_treatment ,Carcinoma in situ ,Arthritis ,Immunotherapy ,medicine.disease ,biology.organism_classification ,Peripheral spondyloarthritis ,Rheumatology ,Immunology ,medicine ,Reactive arthritis ,business ,BCG vaccine - Abstract
Bacillus Calmette-Guerin (BCG) is a vaccine derived from attenuated strains of Mycobacterium bovis. Mycobacterium bovis BCG-based therapy is considered an effective alternative for bladder carcinoma in situ when exclusive transurethral resection is inadequate. Among the complications associated with therapy, there are few reports in the literature on reactive arthritis. We report the case of a 56-year-old woman who develops predominantly peripheral spondyloarthritis, following instillation of BCG, as preventive treatment of relapse onset high-grade urothelial carcinoma after surgical resection.
- Published
- 2014
- Full Text
- View/download PDF